免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

NCT:NCT05082077 · ENROLLING_BY_INVITATION

NCT IDNCT05082077
狀態ENROLLING_BY_INVITATION
開始日期2022-03-15
SponsorParagonix Technologies (INDUSTRY)
First posted
Last updated

簡要摘要

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑